Skip to Main Content

Author Details

Kwang-Soo Kim
McLean Hospital and Program in Neuroscience, Harvard Medical School
1991
245
61
PMIDPaper TitleJournal TitlePublished Year
36628428Current Status and Future Perspectives on Stem Cell-Based Therapies for Parkinson's Disease.J Mov Disord2023
36949040Checkpoint kinase 1/2 inhibition potentiates anti-tumoral immune response and sensitizes gliomas to immune checkpoint blockade.Nat Commun2023
37438521Co-transplantation of autologous T<sub>reg</sub> cells in a cell therapy for Parkinson's disease.Nature2023
37463889An optimized Nurr1 agonist provides disease-modifying effects in Parkinson's disease models.Nat Commun2023
35140411Spotting-based differentiation of functional dopaminergic progenitors from human pluripotent stem cells.Nat Protoc2022
35636646A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson's disease.Neurobiol Dis2022
35600932Integrative analysis of mitochondrial metabolic dynamics in reprogramming human fibroblast cells.STAR Protoc2022
35858708ELK3 modulates the antitumor efficacy of natural killer cells against triple negative breast cancer by regulating mitochondrial dynamics.J Immunother Cancer2022
36175895Enhanced natural killer cell anti-tumor activity with nanoparticles mediated ferroptosis and potential therapeutic application in prostate cancer.J Nanobiotechnology2022
35120329Letter to the Editor. Cell therapy for Parkinson's disease.J Neurosurg2022
33479411Potent synthetic and endogenous ligands for the adopted orphan nuclear receptor Nurr1.Exp Mol Med2021
33926775Interferon-γ inhibits retinal neovascularization in a mouse model of ischemic retinopathy.Cytokine2021
33918941Recent Advances to Augment NK Cell Cancer Immunotherapy Using Nanoparticles.Pharmaceutics2021
33798419A step closer to autologous cell therapy for Parkinson's disease.Cell Stem Cell2021
34965411SIRT2 regulates mitochondrial dynamics and reprogramming via MEK1-ERK-DRP1 and AKT1-DRP1 axes.Cell Rep2021
34815418Identification of disease-linked hyperactivating mutations in UBE3A through large-scale functional variant analysis.Nat Commun2021
34165964Magneto-Activation and Magnetic Resonance Imaging of Natural Killer Cells Labeled with Magnetic Nanocomplexes for the Treatment of Solid Tumors.ACS Nano2021
31214702Columnar Injection for Intracerebral Cell Therapy.Oper Neurosurg (Hagerstown)2020
31985064Investigation of suitable seed sizes, segregation of ripe seeds, and improved germination rate for the commercial production of hemp sprouts (Cannabis sativa L.).J Sci Food Agric2020
31714896Human autologous iPSC-derived dopaminergic progenitors restore motor function in Parkinson's disease models.J Clin Invest2020
31759855Hydrothermal-process-based direct extraction of polydisperse lignin microspheres from black liquor and their physicochemical characterization.Bioresour Technol2020
33463754Toward a Personalized Approach to Parkinson's Cell Therapy.Mov Disord2020
33290037Cationic Nanoparticle-Mediated Activation of Natural Killer Cells for Effective Cancer Immunotherapy.ACS Appl Mater Interfaces2020
32392385TGFam-Finder: a novel solution for target-gene family annotation in plants.New Phytol2020
32411918XRP44X Enhances the Cytotoxic Activity of Natural Killer Cells by Activating the c-JUN N-Terminal Kinase Signaling Pathway.Dev Reprod2020
32402162Personalized iPSC-Derived Dopamine Progenitor Cells for Parkinson's Disease.N Engl J Med2020
32451509PGE1 and PGA1 bind to Nurr1 and activate its transcriptional function.Nat Chem Biol2020
30515963Nurr1 (NR4A2) regulates Alzheimer's disease-related pathogenesis and cognitive function in the 5XFAD mouse model.Aging Cell2019
31729416Maternal and early postnatal immune activation produce sex-specific effects on autism-like behaviors and neuroimmune function in mice.Sci Rep2019
31839743Critical Roles of E2F3 in Growth and Musculo-skeletal Phenotype in Mice.Int J Med Sci2019
31664129Chloroquine modulates inflammatory autoimmune responses through Nurr1 in autoimmune diseases.Sci Rep2019
31182803ELK3 expressed in lymphatic endothelial cells promotes breast cancer progression and metastasis through exosomal miRNAs.Sci Rep2019
31610733The optimal mixing ratio of <i>Brassica napus</i> and <i>Brassica juncea</i> meal improve nematode <i>Meloidogyne hapla</i> effects.Plant Signal Behav2019
31511359ZEB1 Collaborates with ELK3 to Repress E-Cadherin Expression in Triple-Negative Breast Cancer Cells.Mol Cancer Res2019
31419655Multifunctional nanoparticles for genetic engineering and bioimaging of natural killer (NK) cell therapeutics.Biomaterials2019
30654843Ell3 functions as a critical decision maker at the crossroad between stem cell senescence and apoptosis.Stem Cell Res Ther2019
29653250Pluripotent stem cell-based therapy for Parkinson's disease: Current status and future prospects.Prog Neurobiol2018
29491010Maternal and Early Postnatal Immune Activation Produce Dissociable Effects on Neurotransmission in mPFC-Amygdala Circuits.J Neurosci2018
29375705Novel function of E26 transformation-specific domain-containing protein ELK3 in lymphatic endothelial cells.Oncol Lett2018
29510139ELK3-GATA3 axis modulates MDA-MB-231 metastasis by regulating cell-cell adhesion-related genes.Biochem Biophys Res Commun2018
28588704Ell3 stimulates 5-FU resistance in a breast cancer cell line.Oncol Lett2017
28413000Derivation of mouse embryonic stem cell lines from tyrosine hydroxylase reporter mice crossed with a human SNCA transgenic mouse model of Parkinson's disease.Stem Cell Res2017
28436968Metabolic control of primed human pluripotent stem cell fate and function by the miR-200c-SIRT2 axis.Nat Cell Biol2017
28109285Korean mistletoe (Viscum album coloratum) extract regulates gene expression related to muscle atrophy and muscle hypertrophy.BMC Complement Altern Med2017
28360200Toward neuroprotective treatments of Parkinson's disease.Proc Natl Acad Sci U S A2017
28191758Preclinical Analysis of Fetal Human Mesencephalic Neural Progenitor Cell Lines: Characterization and Safety In Vitro and In Vivo.Stem Cells Transl Med2017
28188790The role of ELK3 to regulate peritumoral lymphangiogenesis and VEGF-C production in triple negative breast cancer cells.Biochem Biophys Res Commun2017
28883785Early Postnatal but Not Late Adult Neurogenesis Is Impaired in the Pitx3-Mutant Animal Model of Parkinson's Disease.Front Neurosci2017
28674176Effects of Chronic Social Defeat Stress on Sleep and Circadian Rhythms Are Mitigated by Kappa-Opioid Receptor Antagonism.J Neurosci2017
25407931MiR-126 Regulates Growth Factor Activities and Vulnerability to Toxic Insult in Neurons.Mol Neurobiol2016
  • 1 - 50 of 245

Recommended Authors

German Cancer Research Center (DKFZ)
Career Start Year 2007
Number of shared co-authors 0
China Tobacco Jiangsu Industrial Co. Ltd.
Career Start Year 2007
Number of shared co-authors 0
Department of Pediatrics/Rady Children's Hospital, University of California San Diego
Career Start Year 2006
Number of shared co-authors 0
Pfizer Neuroscience and Pain Research Unit, Pfizer Ltd.
Career Start Year 2004
Number of shared co-authors 0
Department of Pediatrics/Rady Children's Hospital, University of California San Diego
Career Start Year 2004
Number of shared co-authors 0
Department of Pharmacy, Fuzhou Second Hospital
Career Start Year 2003
Number of shared co-authors 0
The Scripps Research Institute
Career Start Year 2003
Number of shared co-authors 0
Emory University School of Medicine
Career Start Year 2003
Number of shared co-authors 0
College of Food Science and Technology, Nanjing Agricultural University
Career Start Year 1999
Number of shared co-authors 0
Department of Pediatrics/Rady Children's Hospital, University of California San Diego
Career Start Year 1999
Number of shared co-authors 1
College of Medicine, Korea University
Career Start Year 1997
Number of shared co-authors 0
Kumamoto University
Career Start Year 1997
Number of shared co-authors 0
Delaware State University
Career Start Year 1997
Number of shared co-authors 0
University of California
Career Start Year 1996
Number of shared co-authors 0
Johns Hopkins University School of Medicine.
Career Start Year 1994
Number of shared co-authors 1
The Florey Institute for Neuroscience and Mental Health, University of Melbourne
Career Start Year 1994
Number of shared co-authors 0
National Institute on Aging, National Institutes of Health
Career Start Year 1992
Number of shared co-authors 2
University of California san francisco
Career Start Year 1990
Number of shared co-authors 1
Istituto Italiano di Tecnologia
Career Start Year 1989
Number of shared co-authors 0
J. David Gladstone Institutes
Career Start Year 1988
Number of shared co-authors 4
Icahn School of Medicine at Mount Sinai
Career Start Year 1988
Number of shared co-authors 0
Institute for Cell Engineering, Johns Hopkins University School of Medicine
Career Start Year 1988
Number of shared co-authors 2
Institute of Developmental Genetics, German Research Center for Environmental Health
Career Start Year 1984
Number of shared co-authors 0
Johns Hopkins University School of Medicine
Career Start Year 1983
Number of shared co-authors 2
Karolinska Institutet.
Career Start Year 1982
Number of shared co-authors 1
Howard Hughes Medical Institute, The Rockefeller University
Career Start Year 1980
Number of shared co-authors 1
Icahn School of Medicine at Mount Sinai
Career Start Year 1980
Number of shared co-authors 1
Vollum Institute, Oregon Health and Science University
Career Start Year 1978
Number of shared co-authors 0
University of Alabama at Birmingham
Career Start Year 1977
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 1973
Number of shared co-authors 1

Collaborators

McLean Hospital and Program in Neuroscience, Harvard Medical School
Co-authored papers 17
Center for Bionano Intelligence Education and Research, Hanyang University
Co-authored papers 11
Harvard Medical School
Co-authored papers 9
Massachusetts General Hospital, Harvard Medical School
Co-authored papers 9
McLean Hospital, Harvard Medical School
Co-authored papers 8
Massachusetts General Hospital and Harvard Medical School
Co-authored papers 7
McLean Hospital, Harvard Medical School
Co-authored papers 7
Department of Psychiatry and McLean Hospital, Harvard Medical School
Co-authored papers 7
Vanderbilt University Medical Center
Co-authored papers 6
College of Medicine, The Catholic University of Korea
Co-authored papers 6
Yonsei University College of Medicine, Republic of Korea S. Biomedics Co.
Co-authored papers 6
Seoul National University
Co-authored papers 5
University of Toronto
Co-authored papers 4
Harvard Medical School
Co-authored papers 4
Joslin Diabetes Center, Harvard Medical School
Co-authored papers 3
Helen and Robert Appel Alzheimer's Disease Research Institute, Cornell University
Co-authored papers 3
Boston Children's Hospital, Seoul National University, Seoul National University Hospital
Co-authored papers 3
McLean Hospital and Program in Neuroscience, Harvard Medical School
Co-authored papers 3
Co-authored papers 2
McLean Hospital, Harvard Medical School
Co-authored papers 2
Co-authored papers 2
Children's Hospital Boston
Co-authored papers 2
Northwestern University Feinberg School of Medicine
Co-authored papers 2
24472McLean Hospital
Co-authored papers 2
College of Life Science, CHA University
Co-authored papers 2
Northwestern University
Co-authored papers 1
Weill Cornell Medicine/New York Presbyterian Hospital
Co-authored papers 1
McLean Hospital, Harvard Medical School
Co-authored papers 1
University of California san francisco
Co-authored papers 1
Harvard Medical School
Co-authored papers 1